Literature DB >> 11255188

Both cyclooxygenase-1 and cyclooxygenase-2 mediate osteoblast response to titanium surface roughness.

B D Boyan1, C H Lohmann, M Sisk, Y Liu, V L Sylvia, D L Cochran, D D Dean, Z Schwartz.   

Abstract

Previous studies suggest that the enhanced expression of the osteoblastic phenotype exhibited by MG63 osteoblast-like cells on rough Ti surfaces (R(a) 4-5 microm) involves increased production of prostaglandin. Inhibition of prostaglandin synthesis by indomethacin blocks surface-roughness-dependent decreases in cell proliferation and increases in alkaline phosphatase activity and the production of osteocalcin and TGF-beta1. This study examined the hypothesis that the increase in expression of the osteoblastic phenotype noted in MG63 cells cultured on rough Ti surfaces is mediated by inducible cyclooxygenase-2 (Cox-2) whereas Cox-1 modulates prostaglandin production and phenotypic expression of the cells under standard conditions and on smooth Ti surfaces. MG63 cells were cultured on tissue culture plastic, smooth Ti (PT, R(a) = 0.60 microm), and two rough Ti surfaces with differing morphologies (SLA, R(a) = 3.97 microm and TPS, R(a) = 5.21 microm). At 24 h after plating, media were replaced with media containing the general Cox inhibitor indomethacin (10(-7)M), the Cox-1 inhibitor resveratrol (1 or 10 microM), or the Cox-2 inhibitor NS-398 (1 or 10 microM). Media were changed again after 48 h. Five days after plating, osteocalcin, PGE(2), and TGF-beta1 content of the conditioned media were determined. Cell numbers were assessed in the same cultures used for determination of osteocalcin production. Cell layer protein and alkaline phosphatase specific activity were assessed in cultures used to measure PGE(2) and TGF-beta1. Indomethacin, resveratrol, and NS-398 had no effect on cell number. Indomethacin blocked the surface-roughness-dependent increase in PGE(2) production by up to 80%. Similarly, resveratrol inhibited up to 50% of the PGE(2) production on smooth surfaces and up to 80% on rough surfaces. In contrast, NS-398 had no effect on PGE(2) production by cells on smooth surfaces but caused a 60% reduction in cultures on rough surfaces. Indomethacin reduced alkaline phosphatase on all surfaces below basal levels. However, neither resveratrol nor NS-398 had an effect. Indomethacin blocked the stimulatory effect of surface roughness on osteocalcin production while resveratrol only partially reduced osteocalcin production, and NS398 completely blocked the surface-dependent increase. TGF-beta1 production on rough surfaces was blocked by indomethacin. The effects of resveratrol and NS-398 were dose dependent, but neither agent caused total inhibition of the increase noted on SLA, and only resveratrol blocked the increase on TPS. These results indicate that both Cox-1 and Cox-2 are involved in the response of osteoblasts to surface roughness with respect to production of PGE(2), TGF-beta1, and osteocalcin. While prostaglandin mediates the effects of surface roughness on alkaline phosphatase, neither Cox-1 nor Cox-2 appears to be involved, at least with respect to the two inhibitors used. Copyright 2001 John Wiley & Sons, Inc. J Biomed Mater Res 55: 350-359, 2001

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11255188     DOI: 10.1002/1097-4636(20010605)55:3<350::aid-jbm1023>3.0.co;2-m

Source DB:  PubMed          Journal:  J Biomed Mater Res        ISSN: 0021-9304


  15 in total

1.  No evidence to indicate topographic dependency on bone formation around cp titanium implants under masticatory loading.

Authors:  H Kawahara; H Aoki; H Koike; Y Soeda; D Kawahara; S Matsuda
Journal:  J Mater Sci Mater Med       Date:  2006-08       Impact factor: 3.896

2.  Effect of micrometer-scale roughness of the surface of Ti6Al4V pedicle screws in vitro and in vivo.

Authors:  Zvi Schwartz; Perry Raz; Ge Zhao; Yael Barak; Michael Tauber; Hai Yao; Barbara D Boyan
Journal:  J Bone Joint Surg Am       Date:  2008-11       Impact factor: 5.284

Review 3.  [Resorbable bone substitution materials: An overview of commercially available materials and new approaches in the field of composites].

Authors:  S Heinemann; M Gelinsky; H Worch; T Hanke
Journal:  Orthopade       Date:  2011-09       Impact factor: 1.087

4.  Osteoblasts exhibit a more differentiated phenotype and increased bone morphogenetic protein production on titanium alloy substrates than on poly-ether-ether-ketone.

Authors:  Rene Olivares-Navarrete; Rolando A Gittens; Jennifer M Schneider; Sharon L Hyzy; David A Haithcock; Peter F Ullrich; Zvi Schwartz; Barbara D Boyan
Journal:  Spine J       Date:  2012-03-15       Impact factor: 4.166

5.  Nanotechnology for surgeons.

Authors:  Shrikant Mali
Journal:  Indian J Surg       Date:  2012-09-20       Impact factor: 0.656

6.  The role of phospholipase D in osteoblast response to titanium surface microstructure.

Authors:  Mimi Fang; Rene Olivares-Navarrete; Marco Wieland; David L Cochran; Barbara D Boyan; Zvi Schwartz
Journal:  J Biomed Mater Res A       Date:  2010-06-01       Impact factor: 4.396

7.  Response of bone marrow derived connective tissue progenitor cell morphology and proliferation on geometrically modulated microtextured substrates.

Authors:  Eun Jung Kim; Aaron J Fleischman; George F Muschler; Shuvo Roy
Journal:  Biomed Microdevices       Date:  2013-06       Impact factor: 2.838

8.  Rough titanium alloys regulate osteoblast production of angiogenic factors.

Authors:  Rene Olivares-Navarrete; Sharon L Hyzy; Rolando A Gittens; Jennifer M Schneider; David A Haithcock; Peter F Ullrich; Paul J Slosar; Zvi Schwartz; Barbara D Boyan
Journal:  Spine J       Date:  2013-05-14       Impact factor: 4.166

9.  Post microtextures accelerate cell proliferation and osteogenesis.

Authors:  Eun Jung Kim; Cynthia A Boehm; Alvaro Mata; Aaron J Fleischman; George F Muschler; Shuvo Roy
Journal:  Acta Biomater       Date:  2009-06-16       Impact factor: 8.947

10.  Mechanisms regulating increased production of osteoprotegerin by osteoblasts cultured on microstructured titanium surfaces.

Authors:  Zvi Schwartz; Rene Olivares-Navarrete; Marco Wieland; David L Cochran; Barbara D Boyan
Journal:  Biomaterials       Date:  2009-04-23       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.